Lymphoma, a cancer of the immune system, is silently ravaging the health of Black men across America. This insidious disease, ...

When it was time to decide where he wanted to work, Dalton Cummins tells PEOPLE that going back to the hospital where he beat ...

Two main types of lymphocytes exist: T cells and B cells. Diffuse Large B-cell Lymphoma (DLBCL) specifically involves the unchecked growth of B cells. This type of lymphoma is known for its rapid ...

Medscape Medical News, January 22, 2013 Rituximab for Low-Risk Diffuse Large B-Cell Lymphoma Progression-free survival in younger patients with low-risk localized diffuse large B-cell lymphoma ...

Strengthens Lyell’s clinical pipeline with the addition of IMPT-314, a dual-targeting CD19/CD20 CAR T-cell product candidateData from ImmPACT’s ...

NICE has approved Novartis’ CAR-T therapy Kymriah (tisagenlecleucel) for diffuse large B-cell lymphoma (DLBCL) in adults who did not respond to two or more previous treatments.

EPKINLY is a treatment for adult patients with Relapsed or Refractory diffuse large B-cell lymphoma (R/R DLBCL) not otherwise specified, DLBCL transformed from indolent lymphoma, high grade B-cell ...

India continues to see a steady rise in the incidence of lymphoma, the most common type of blood cancer. But among all the ...

A mouse xenograft model of DLBCL tumors was used to characterize the role of TNFAIP3 expression tumor growth. Tumors induced from cells with higher levels of TNFAIP3 had a lower volume compared with ...

Elizabeth A. Brem, MD, discusses the shift she has seen in the community setting when it comes to using bispecific antibody ...

AbbVie (NYSE: ABBV) today announced that nine provinces have provided accelerated public coverage of EPKINLY™. EPKINLY is a treatment for adult patients with Relapsed or Refractory diffuse large ...